A pilot study on the impact of Hydroxiram D supplementation on nutritional status and sarcopenia-related parameters
Sarcopenia is a frequent and prognostically relevant complication of chronic liver disease. The SARCIRAM pilot trial investigated the effect of Hydroxiram D, a formulation of branched-chain amino acids (BCAAs), β-hydroxy-β-methylbutyrate (HMB), and vitamin D, on nutritional status and sarcopenia-related parameters in patients with compensated cirrhosis due to metabolic dysfunction-associated steatotic liver disease (MASLD). In this single-center, randomized pilot study, adults with compensated MASLD-related cirrhosis (Child-Pugh A) received Hydroxiram D plus standard care or standard care alone for 6 months. The primary outcome was phase angle (PA), while secondary outcomes were appendicular skeletal muscle mass (ASMM)/height², handgrip strength (HGS), and 4-meter walk test (4-mWT). Between-group comparisons used baseline-adjusted models. Post-hoc simulation analyses were used exploratorily to inform the design of future studies. Thirty-two patients were analyzed. After 6 months, the adjusted change in PA was significantly more favorable in the treated group versus controls (+ 0.36° vs. - 0.45°, p = 0.046). Between-group differences in muscle mass, HGS, and gait speed were not statistically significant, although effect estimates directionally favoured the intervention. No treatment-related adverse events were observed. Six months of Hydroxiram D was associated with a more favorable change in PA in patients with compensated MASLD-related cirrhosis, with favorable trends in muscle parameters. These hypothesis-generating findings warrant confirmation in larger, prospectively registered, double-blind trials to confirm efficacy and long-term outcomes.
Authors
- Paolo Gallo (ORCID: https://orcid.org/0000-0001-8292-1134)
- Francesca Terracciani (ORCID: https://orcid.org/0000-0002-4778-4194)
- Andrea Falcomatà (ORCID: https://orcid.org/0000-0002-4523-130X)
- Umberto Vespasiani‐Gentilucci (ORCID: https://orcid.org/0000-0002-1138-1967)
- Giorgio Reggiardo (ORCID: https://orcid.org/0000-0003-4237-6797)
- Simone Di Cola (ORCID: https://orcid.org/0000-0002-6414-4404)
- Antonio Picardi (ORCID: https://orcid.org/0000-0002-0230-218X)
- Raffaele AntonelliIncalzi
- Antonio De Vincentis (ORCID: https://orcid.org/0000-0003-0220-0500)
- Valentina Flagiello (ORCID: https://orcid.org/0009-0004-0887-2265)
- Dafne Marcelli
- Lucrezia Santoro
Institutions
- Università Campus Bio-Medico (IT)
- Karolinska Institutet (SE)
- Consorzio per Valutazioni Biologiche e Farmacologiche (IT)
- Campus Bio Medico University Hospital (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Physiology and Biochemistry
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1007/s13105-026-01253-4
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Karolinska Institutet